KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Shares Outstanding (2016 - 2025)

Cvs Health (CVS) has disclosed Shares Outstanding for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 0.51% year-over-year to $1.8 billion, compared with a TTM value of $1.8 billion through Dec 2025, up 0.51%, and an annual FY2025 reading of $1.8 billion, up 0.51% over the prior year.
  • Shares Outstanding was $1.8 billion for Q4 2025 at Cvs Health, roughly flat from $1.8 billion in the prior quarter.
  • Across five years, Shares Outstanding topped out at $1.8 billion in Q4 2025 and bottomed at $1.7 billion in Q1 2021.
  • Average Shares Outstanding over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2023.
  • Peak annual rise in Shares Outstanding hit 512.06% in 2021, while the deepest fall reached 0.35% in 2021.
  • Year by year, Shares Outstanding stood at $1.7 billion in 2021, then grew by 0.8% to $1.8 billion in 2022, then grew by 0.57% to $1.8 billion in 2023, then increased by 0.57% to $1.8 billion in 2024, then rose by 0.51% to $1.8 billion in 2025.
  • Business Quant data shows Shares Outstanding for CVS at $1.8 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.8 billion in Q2 2025.